Power of Story Send a Tweet        
- Advertisement -
General News

Martin Shkreli walks back on pledge to lower price of HIV drug Daraprim

Quicklink Submitted By   Follow Me on Twitter     Message Sheila Samples     Permalink

Related Topic(s): ; ; , Add Tags  

Must Read 1   Valuable 1  
View Ratings | Rate It

opednews.com Headlined to H4 11/27/15

Become a Fan
  (46 fans)
From youtube.com/watch?v=WVIgveDesEY: Price Gouging Drug CEO Martin Shkreli
Price Gouging Drug CEO Martin Shkreli
(Image by The Young Turks, Channel: TheYoungTurks)
  Permission   Details   DMCA

Controversial pharmaceutical boss Martin Shkreli has has decided he’s not going to lower the price of his HIV medication after all. Shkreli’s company Turing Pharmaceuticals announced on Wednesday that it would provide volume discounts of its drug Daraprim to hospitals, but it appears that the company’s $750-a-pill price tag still stands. Turing and Shkreli attracted a firestorm of criticism in September after it was revealed the company had raised the price of Daraprim, a 62-year-old treatment for parasitic infections, to $750 a pill from $13.50 after acquiring it. The medicine once sold for $1 a pill.
Read the rest of the story HERE:

At www.theguardian.com

 

- Advertisement -

Must Read 1   Valuable 1  
View Ratings | Rate It

opednews.com

Sheila Samples is an Oklahoma writer and a former civilian US Army Public Information Officer. She is a Managing Editor for OpEd News, and a regular contributor for a variety of Internet sites.

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon Share Author on Social Media   Go To Commenting

The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Follow Me on Twitter

Writers Guidelines

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
- Advertisement -